Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cell therapy
cell therapy
Vertex, continuing its rebound, cleared to resume testing of diabetes cell therapy
BioPharma Dive
Wed, 07/6/22 - 10:33 am
Vertex Pharmaceuticals
type 1 diabetes
cell therapy
FDA
Galapagos to enter cell therapy space with acquisition of CellPoint and AboundBio
Seeking Alpha
Tue, 06/21/22 - 11:50 pm
Galapagos
cell therapy
CellPoint
AboundBio
CAR-T
Taking Charge—biotechs already approaching Novartis to partner on 'game changing' CAR-T platform
Fierce Biotech
Tue, 06/14/22 - 11:18 am
Novartis
CAR-T
cell therapy
T-Charge
bluebird bio Blazes Trail for Lentiviral Vectors at Upcoming FDA Meeting
BioSpace
Tue, 06/7/22 - 11:57 pm
Bluebird Bio
lentiviral vectors
FDA
cell therapy
Prettying itself up for partners, Athersys lays off 70% of staff and most of C-suite
Fierce Biotech
Fri, 06/3/22 - 09:09 am
Athersys
layoffs
cell therapy
stem cells
Inceptor Bio generates $37m in funding round as it advances CAR-T platform into the clinic
Biopharma Reporter
Wed, 05/25/22 - 10:13 am
Inceptor Bio
CAR-T
funding
cell therapy
cancer
CAR T without the toxicity: Kelonia gets $50M for a new take on cell therapy
MedCity News
Sun, 05/22/22 - 09:06 pm
Kelonia Therapeutics
CAR-T
cell therapy
funding
FDA explains plans to bolster cell and gene therapy approvals through wider messaging
RAPS.org
Thu, 05/19/22 - 09:01 pm
FDA
regulatory
cell therapy
gene therapy
Inceptor Bio Announces $37 Million Series A Financing to Develop Cell Therapies for Difficult-to-Treat Cancers
BioSpace
Thu, 05/19/22 - 10:52 am
Inceptor Bio
cancer
cell therapy
funding
Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center
Fierce Biotech
Tue, 05/17/22 - 10:54 am
Vertex Pharmaceuticals
Boston
cell therapy
gene therapy
Can FDA replicate Operation Warp Speed for rare diseases? Not yet, but Peter Marks has some ideas
Fierce Biotech
Wed, 05/11/22 - 10:29 am
FDA
Peter Marks
CBER
gene therapy
cell therapy
Operation Warp Speed
Rare Diseases
Aiming to treat Parkinson’s by replacing neurons, Aspen Neuroscience nabs $147M
MedCity News
Mon, 05/9/22 - 11:22 pm
Aspen Neuro
Parkinson's Disease
stem cells
Bayer
cell therapy
Bone Therapeutics is Breaking New Ground in Bone Remodeling
BioSpace
Mon, 05/9/22 - 10:08 am
Bone Therapeutics
bone remodeling
cell therapy
bone fractures
BMS shows what’s NEX-T for CAR T, plus its strategy for next-gen cancer cell therapy
MedCity News
Wed, 05/4/22 - 10:35 am
Bristol Myers Squibb
Kristen Hege
CAR-T
cell therapy
WMIF panel: How cell and gene therapy can overcome limitations of CAR T
MedCity News
Tue, 05/3/22 - 10:35 am
CAR-T
cell therapy
gene therapy
solid tumors
World Medical Innovation Forum
Cell therapy biotech Aurion gets $120M to restore vision and revamp organ donor economics
MedCity News
Tue, 04/12/22 - 08:35 pm
Aurion
organ donation
cell therapy
clinical trials
FDA releases draft guidance for cell and gene therapies
Biopharma Reporter
Wed, 04/6/22 - 11:35 am
FDA
regulatory
cell therapy
gene therapy
CAR-T
Bayer reloads Leaps with €1.3 billion to step up investments in biotech innovation
MedCity News
Mon, 04/4/22 - 10:19 am
Bayer
Leaps by Bayer
innovation
artificial intelligence
gene therapy
cell therapy
funding
Intellia's CRISPR-engineered cell therapy secures FDA orphan drug status after AML trial launch
Fierce Biotech
Wed, 03/9/22 - 11:13 pm
Intellia Therapeutics
CRISPR
FDA
cell therapy
orphan drugs
GPB Scientific becomes Curate Biosciences, targets 50% reduction in autologous cell therapy costs
Biopharma Reporter
Thu, 02/10/22 - 10:21 am
GPB Scientific
Curate Biosciences
rebranding
cell therapy
gene therapy
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »